Seven Eight Capital, LP 10x Genomics, Inc. Transaction History

Seven Eight Capital, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$19.45 - $37.37 $1.24 Million - $2.39 Million	-63,954 Reduced 64.03%	35,924 $698,000
Q1 2024 May 13, 2024	BUY	$36.08 - $54.3 $3.6 Million - $5.42 Million	99,878 New	99,878 $3.75 Million
Q3 2023 Nov 14, 2023	BUY	$40.86 - $62.98 $415,178 - $639,939	10,161 New	10,161 $419,000
Q3 2022 Nov 10, 2022	BUY	$28.48 - $52.59 $542,857 - $1 Million	19,061 New	19,061 $543,000
Q2 2021 Aug 13, 2021	SELL	$134.22 - $202.37 $201,330 - $303,555	-1,500 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$126.47 - $163.7 $214,999 - $278,290	-1,700 Reduced 53.13%	1,500 $212,000
Q3 2020 Nov 16, 2020	BUY	$87.44 - $125.0 $279,808 - $400,000	3,200 New	3,200 $399,000
Q2 2020 Aug 06, 2020	SELL	$58.39 - $89.31 $321,145 - $491,205	-5,500 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$51.57 - $106.62 $283,635 - $586,410	5,500 New	5,500 $343,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.